Seoul, South Korea

Jin-Hong Kim

This inventor holds 36 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Semiconductor Devices. Top assignees: Samsung Electronics Co., Ltd., Taewoong Medical Co., Ltd., Dongsung Chemical Co., Ltd.. Active years: 1993-2025.

USPTO Granted Patents = 36 

% Patents Active = 75.0


 

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 267(Granted Patents)


Location History:

  • Kyungki-do, KR (1997 - 2000)
  • Incheon, KR (2009)
  • Yongin-si, KR (2006 - 2011)
  • Kyunggi-do, KR (2004 - 2013)
  • Suwon, KR (1993 - 2019)
  • Suwon-si, KR (2008 - 2021)
  • Seoul, KR (2007 - 2023)
  • Hwaseong-si, KR (2022 - 2023)

Company Filing History:


Years Active: 1993-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thin Film Transistor
Stacked Semiconductor Device
Nonvolatile Memory
Firmware Update
Toner Cartridge
Liquid Crystal Display
Photosensor
Aqueous Polyurethane
DC-DC Converter
Chondrosarcoma Treatment
Esophageal Stent
Magneto-Optical Recording
36 patents (USPTO):Explore Patents

Title: Jin-Hong Kim: A Pioneer in Patents and Innovations

Introduction

Jin-Hong Kim, based in Seoul, South Korea, is a distinguished inventor with a remarkable portfolio of 34 patents. His work primarily focuses on technological advancements and medical innovations, showcasing his ability to bridge these two fields through inventive solutions.

Latest Patents

Among his latest contributions to the world of inventions are two significant patents. The first, titled "Method and Device for Updating Firmware Using a Modified Delta File," outlines a sophisticated method for updating firmware that enhances efficiency. It includes generating a series of delta files by manipulating blocks based on update areas, ultimately facilitating a streamlined process for firmware updates.

The second patent, "Use of HIF-2α Inhibitors for Treating Chondrosarcoma, or Preventing Recurrence and Metastasis Thereof," presents a novel approach for treating chondrosarcoma. This invention focuses on regulating HIF-2α to effectively combat the disease, specifically targeting dedifferentiated chondrosarcoma's progression and recurrence.

Career Highlights

Jin-Hong Kim has made significant strides throughout his career. He has been an influential figure at companies like Samsung Electronics Co., Ltd. and Taewoong Medical Co., Ltd. His roles at these organizations have allowed him to refine his skills and innovate solutions that contribute to both the technology and medical fields.

Collaborations

Collaboration is key in the world of innovation, and Jin-Hong Kim has partnered with notable colleagues such as Chong-Chul Chai and Kyoung-Ju Shin. Their collective efforts have led to breakthroughs that exemplify the power of teamwork in research and development.

Conclusion

In summary, Jin-Hong Kim's contributions to technology and medicine highlight him as a prominent inventor with a clear vision for the future. His patents not only reflect his expertise but also his commitment to improving lives through innovative solutions. As he continues to work and collaborate, the impact of his inventions will surely resonate for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…